A drug with the SMILES NC(=O)C1CCN(C(=O)c2ccc([N+](=O)[O-])cc2NC(=O)c2cccs2)CC1 has a human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM of 0.861%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
NC(=O)C1CCN(C(=O)c2ccc([N+](=O)[O-])cc2NC(=O)c2cccs2)CC1
NC(=O)C1CCN(C(=O)c2ccc([N+](=O)[O-])cc2NC(=O)c2cccs2)CC1
[4-(4-carbamoylpiperidine-1-carbonyl)-3-(thiophene-2-carbonylamino)phenyl]-oxido-oxoazanium